July 31, 2014 5:35 AM ET

Diversified Financial Services

Company Overview of Shire Finance Ltd.

Company Overview

Shire Finance, Ltd. operates as a pharmaceutical company focusing on three therapeutic areas, including central nervous systems disorders, oncology, and anti-infectives. It has two technology platforms: drug delivery and biologics. The company’s main products include Adderall, for the treatment of Attention Deficit Hyperactivity Disorder; Agrylin for the treatment of elevated blood platelets; Pentasa for the treatment of ulcerative colitis; Carbatrol for the treatment of epilepsy; ProAmatine for the treatment of orthostatic hypotension; the Calcichew range for the treatment of osteoporosis; Reminyl for the treatment of Alzheimer's disease; 3TC for the treatment of HIV/AIDS; Combivir and Hept...

International Business Park

Chineham

Basingstoke,  RG24 8EP

United Kingdom

Phone:

44 12 5689 4000

Key Executives for Shire Finance Ltd.

Chief Executive Officer
Age: 70
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Avebury Capital Partners LLP Europe
1st Credit Ltd. Europe
John Martin Holdings Ltd Europe
Bigben Interactive Uk Holdings Ltd Europe
Dalmore Capital (Issuer 1) Ltd. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Shire Finance Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.